M2 Analyzer
Portable CLIA for Covid-19
Languages: English
: pll_5ed8d924cf480
Sectors: Clinic
Areas: Biochemistry, Emergencies, Laboratory, Medical consultation, Microbiology, Pediatrics
Product lines: Covid-19, Immunology, Point of Care
The first rapid portable chemiluminescence assay for the quantitative detection of antibodies against Covid-19 is now available.
The world’s first CLIA-based portable diagnostic solution for the COVID-19, reduces response time to result, minimizes risk. of infection
Product features:
- Compact design (min.4.5Kg) and maintenance-free
- Integrated thermostat for reactions at 37ºC
- Monotest (IgM or IgG) or multitest (IgA, IgM, IgE, IgD, IgG) sensor card
- High sensitivity and specificity quantitative measure.
- Ideal for seroprevalence study or for PCR monitoring – / +
- Quick results, only 15 minutes.
- Chemiluminescence-based method, immunoassay reference method
- Other available tests: cardiac markers, Dimero D and PCT
- Wide connectivity via GPS, 4G, WIFI, Bluethooth, iCloud
Technical specifications:
| Sample Type | Whole blood / peripheral blood / plasma / serum |
| Sample volume | 5-50μl |
| Test time | 10-15min/test |
| Available tests | NT-proBNP, Toponin I, Myo, CK-MB, D-Dimer, PCT, SARS-CoV-2Ab/lgG/lgM |
| Storage temperature | -20°C a+45°C |
| Power Supply | AC 100V-240V50/60Hz |
| Energy consumption | 300VA |
| Dimensions | 267,5x180x220mm |
| Weight | 4,5kg |
Ask us any doubt and we will give you advice on buying, installation and maintainance
The first rapid portable chemiluminescence assay for the quantitative detection of antibodies against Covid-19 is now available.
The world’s first CLIA-based portable diagnostic solution for the COVID-19, reduces response time to result, minimizes risk of infection.
Request pricingRequest information
